financetom
Market
financetom
/
Market
/
Semtech Beats Q4 Expectations, Analyst Says AI Data Center Demand Outpaces Legacy Business Model
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Semtech Beats Q4 Expectations, Analyst Says AI Data Center Demand Outpaces Legacy Business Model
Mar 17, 2026 8:59 AM

Shares of Semtech Corp ( SMTC ) tanked in early trading on Tuesday, after the company reported fourth-quarter results.

Here are the key analyst insights:

Needham analyst Quinn Bolton maintained a Buy rating, while raising the price target from $100 to $105.

Benchmark analyst Cody Acree reaffirmed a Buy rating and price target of $115.

Check out other analyst stock ratings.

Needham: Semtech ( SMTC ) reported solid results and slightly higher-than-expected revenue guidance for Q1 of fiscal 2027. Bolton highlighted:

Datacenter growth due to ACC adoption and the ramp of 1.6T optical modules in the back half of the year

The acquisition of optoelectronics manufacturer HieFo is expected to be earnings accretive within a year of the deal

LoRa is likely to generate long-term growth of around 20%

Management remains on course to divest non-core assets

Benchmark: Semtech ( SMTC ) posted revenue of $274.4 million and earnings of 44 cents per share. It beat Street expectations by about $1 million and 1 cent per share, respectively. The company guided to first-quarter revenue of $283 million and earnings of 45 cents per share, higher than consensus estimates by around $10 million and 2 cents per share, Acree said.

Investors seem to be concerned about "the durability of the company's data-center-driven inflection against near-term noise in its high-end consumer and industrial businesses and the practical realities of an extended period of laser capacity expansion post its HieFo acquisition," the analyst wrote. Semtech ( SMTC ) is "increasingly levered to the AI data center build-out," which is underappreciated compared to its legacy business model, he further stated.

SMTC Price Action: Shares of Semtech ( SMTC ) had declined by 5.54% to $84.06 at the time of publication on Tuesday.

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exchange-Traded Funds, Equity Futures Edge Higher Pre-Bell Tuesday Amid Ongoing Tariff Confusion
Exchange-Traded Funds, Equity Futures Edge Higher Pre-Bell Tuesday Amid Ongoing Tariff Confusion
Mar 25, 2025
08:36 AM EDT, 03/25/2025 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust ( SPY ) was up 0.3% and the actively traded Invesco QQQ Trust (QQQ) advanced 0.2% in Tuesday's premarket activity amid ongoing confusion regarding what tariffs will be implemented by US President Donald Trump. US stock futures also edged higher, with S&P 500...
Sector Update: Tech
Sector Update: Tech
Mar 25, 2025
08:40 AM EDT, 03/25/2025 (MT Newswires) -- Technology stocks were flat to higher pre-bell Tuesday, with the SPDR S&P Semiconductor ETF (XSD) inactive and The Technology Select Sector SPDR Fund (XLK) up 0.3%. ACI Worldwide ( ACIW ) has extended its technology partnership with UK retailer Co-op, the companies said. ACI Worldwide ( ACIW ) shares were more than 2%...
Sector Update: Financial
Sector Update: Financial
Mar 25, 2025
08:50 AM EDT, 03/25/2025 (MT Newswires) -- Financial stocks advanced pre-bell Tuesday, with the Financial Select Sector SPDR Fund (XLF) 0.4% higher recently. The Direxion Daily Financial Bull 3X Shares (FAS) was up 1.1% and its bearish counterpart Direxion Daily Financial Bear 3X Shares (FAZ) was 1.2% lower. Qifu Technology's ( QFIN ) shares were down more than 1% after...
Sector Update: Health Care
Sector Update: Health Care
Mar 25, 2025
08:48 AM EDT, 03/25/2025 (MT Newswires) -- Health care stocks were advancing premarket Tuesday, with The Health Care Select Sector SPDR Fund (XLV) and the iShares Biotechnology ETF (IBB) marginally higher. Alumis ( ALMS ) shares were up over 65% after the company and Kaken Pharmaceutical said they signed a collaboration and licensing agreement to develop, manufacture, and commercialize ESK-001...
Copyright 2023-2026 - www.financetom.com All Rights Reserved